AstraZeneca says reports COVID-19 vaccine efficacy is low in elderly are incorrect

Reuters | Frankfurt | Updated: 26-01-2021 03:26 IST | Created: 26-01-2021 03:15 IST
AstraZeneca says reports COVID-19 vaccine efficacy is low in elderly are incorrect
Representative Image Image Credit: ANI

AstraZeneca on Monday described German media reports saying its COVID-19 vaccine was shown to have a very low efficacy in the elderly as "completely incorrect".

German daily papers Handelsblatt and Bild said in separate reports on Monday the vaccine - co-developed by AstraZeneca and Oxford University - had an efficacy of 8% or less than 10%, respectively, in those over 65 and the German government did not expect the European regulator to approve the product for that age group.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

Tesla to cut Model 3 production in U.S. for two weeks - sources

Electric vehicle maker Tesla Inc plans to slash production of its Model 3 sedans for two weeks, sources told Reuters on Thursday, at a time when demand is slowing for Tesla cars and the market faces a chip shortage.They were not aware of th...

Soccer-Man United stroll into Europa League last 16

Manchester United eased into the Europa league last 16 after a 0-0 home draw with Real Sociedad on Thursday completed a 4-0 aggregate win over the Spanish side in their round of 32 clash. With one eye on Sundays Premier League clash against...

COVID shot is quick and doesn't hurt, says Britain's Queen Elizabeth

Britains 94-year-old Queen Elizabeth, who last month had her first COVID-19 vaccination dose, has said that getting the shot was very quick and did not hurt. The monarch and her 99-year-old husband Prince Philip, who is currently in hospita...

Israeli plan to share vaccines frozen by legal questions

Israeli Prime Minister Benjamin Netanyahus controversial plan to ship surplus coronavirus vaccines to a group of allied nations was frozen Thursday following a legal challenge to the deal, his office announced.It was the latest twist in a s...

Give Feedback